2'-fluorothymidine has been researched along with Cancer of Prostate in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Desai, B; Jadvar, H; Varghese, B; Velez, E | 1 |
Chen, K; Jadvar, H; Ukimura, O | 1 |
Dickow, B; Dobson, K; Heilbrun, LK; Lawhorn-Crews, JM; Shields, AF; Smith, D; Tehrani, OS; Vaishampayan, UN | 1 |
Alauddin, MM; Bading, JR; Bathija, P; Conti, PS; Fissekis, JD; Koda, RT; Koszalka, GW; Shahinian, AH; Vail, A | 1 |
Douglas, KA; Heilbrun, LK; Lawhorn-Crews, JM; Mangner, TJ; Muzik, O; Shields, AF; Sun, H; Tehrani, OS | 1 |
Bading, JR; Bathija, P; Conti, PS; Shahinian, AH | 1 |
1 trial(s) available for 2'-fluorothymidine and Cancer of Prostate
Article | Year |
---|---|
A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [
Topics: Aged; Arabinofuranosyluracil; Biomarkers, Tumor; Bone Neoplasms; Bone Remodeling; Diphosphonates; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Imidazoles; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results; Tomography, X-Ray Computed; Zoledronic Acid | 2017 |
5 other study(ies) available for 2'-fluorothymidine and Cancer of Prostate
Article | Year |
---|---|
Incidental Detection of Meningioma by 18F-FMAU PET/CT in a Patient With Suspected Prostate Cancer.
Topics: Aged; Arabinofuranosyluracil; Fluorine Radioisotopes; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2018 |
Targeted Prostate Gland Biopsy With Combined Transrectal Ultrasound, mpMRI, and 18F-FMAU PET/CT.
Topics: Arabinofuranosyluracil; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats.
Topics: Adenocarcinoma; Animals; Arabinofuranosyluracil; Carbon Radioisotopes; Cell Line, Tumor; Colorectal Neoplasms; DNA, Neoplasm; Female; Male; Metabolic Clearance Rate; Organ Specificity; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Thymidine; Tissue Distribution | 2004 |
Tumor imaging using 1-(2'-deoxy-2'-18F-fluoro-beta-D-arabinofuranosyl)thymine and PET.
Topics: Arabinofuranosyluracil; Brain Neoplasms; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2007 |
Pharmacokinetics of the thymidine analog 2'-fluoro-5-[(14)C]-methyl-1-beta-D-arabinofuranosyluracil ([(14)C]FMAU) in rat prostate tumor cells.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; DNA; Male; Prostatic Neoplasms; Rats; Thymidine; Tumor Cells, Cultured | 2000 |